Physician profile
Young An
NPI 1003808593
$5,246.65
in general payments reported to CMS, 2019-2025
23 companies · $536 in 2025
The $536 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,078 · 2020: $973 · 2021: $1,584 · 2022: $428 · 2023: $225 · 2024: $424 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,184.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,961.03 | 2019-2022 | |
| Optinose US, INC. | $545.73 | 2019-2025 | |
| Aerin Medical INC. | $364.58 | 2022-2025 | |
| Genzyme Corporation | $282.21 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $240.15 | 2019-2025 | Dupixent, Libtayo |
| Glaxosmithkline, LLC. | $215.10 | 2021-2025 | Nucala |
| Intersect Ent, INC. | $189.66 | 2019-2021 | |
| Alk-Abello, INC | $61.51 | 2019-2022 | |
| Inspire Medical Systems, INC. | $54.73 | 2023 | Inspire |
| Amgen INC. | $39.59 | 2025 | Tezspire |
| Resmed Corp | $33.69 | 2024-2025 | |
| Kaleo, INC. | $31.99 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $30.63 | 2023 | |
| Ars Pharmaceuticals Operations, INC. | $28.74 | 2025 | Neffy |
| Jazz Pharmaceuticals INC. | $24.69 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $22.20 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $20.24 | 2025 | Tezspire |
| Medtronic, INC. | $19.25 | 2021 | |
| Fortovia Therapeutics, INC. | $18.62 | 2019 | |
| Cochlear Americas | $18.32 | 2019 | |
| Olympus America INC. | $17.91 | 2019 | |
| Phathom Pharmaceuticals, INC. | $15.03 | 2025 | Voquezna |
| Smith+Nephew, INC. | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Young An listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.